Psychiatric Risk Assessment from the Clinician's Perspective: Lessons for the Future

Alex S. Cohen, Department of Psychology, Louisiana State University, 236 Audubon Hall, Baton Rouge, LA, 70803, USA. acohen@lsu.edu.
Taylor Fedechko, Department of Psychology, Louisiana State University, 236 Audubon Hall, Baton Rouge, LA, 70803, USA.
Elana K. Schwartz, Department of Psychology, Louisiana State University, 236 Audubon Hall, Baton Rouge, LA, 70803, USA.
Thanh P. Le, Department of Psychology, Louisiana State University, 236 Audubon Hall, Baton Rouge, LA, 70803, USA.
Peter W. Foltz, Institute of Cognitive Science, University of Colorado, Boulder, USA.
Jared Bernstein, Analytic Measures Inc, Palo Alto, CA, USA.
Jian Cheng, Analytic Measures Inc, Palo Alto, CA, USA.
Elizabeth Rosenfeld

Abstract

Accurate prediction of risk-states in Serious Mental Illnesses (SMIs) is critical for reducing their massive societal burden. Risk-state assessments are notably inaccurate. Recent innovations, including widely available and inexpensive mobile technologies for ambulatory "biobehavioral" data, can reshape risk assessment. To help understand and accelerate clinician involvement, we surveyed 90 multi-disciplinary clinicians serving SMI populations in various settings to evaluate how risk assessment is conducted and can improve. Clinicians reported considerable variability in conducting risk assessment, and few clinicians explicated their procedures beyond tying it to broader mental status examinations or interviews. Very few clinicians endorsed using currently-available standardized risk measures, and most reported low confidence in their utility. Clinicians also reported spending approximately half the time conducting individual risk assessments than optimally needed. When asked about improvement, virtually no clinicians acknowledged biobehavioral, objective technologies, or ambulatory recording. Overall, clinicians seemed unaware of meaningful ways to improve risk assessment.